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Background: The field of microbiome research is growing rapidly. We developed a method for self-collection of
fecal specimens that can be used in population-based studies of the gut microbiome. We conducted a pilot study
to test the feasibility of our methods among a random sample of healthy, postmenopausal women who are members
of Kaiser Permanente Colorado (KPCO). We aimed to collect questionnaire data, fecal and urine specimens from
60 women, aged 55–69, who recently had a normal screening mammogram. We designed the study such that
all questionnaire data and specimens could be collected at home.
Results: We mailed an invitation packet, consent form and opt-out postcard to 300 women, then recruited by
telephone women who did not opt-out. Verbally consented women were mailed an enrollment package including
a risk factor questionnaire, link to an online diet questionnaire, specimen collection kit, and instructions for collecting
stool and urine. Specimens were shipped overnight to the biorepository. Of the 300 women mailed an invitation
packet, 58 (19%) returned the opt-out postcard. Up to 3 attempts were made to telephone the remaining women,
of whom 130 (43%) could not be contacted, 23 (8%) refused, and 12 (4%) were ineligible. Enrollment packages were
mailed to 77 women, of whom 59 returned the risk factor questionnaire and specimens. We found no statistically
significant differences between enrolled women and those who refused participation or could not be contacted.
Conclusions: We demonstrated that a representative sample of women can be successfully recruited for a gut
microbiome study; however, significant personal contact and carefully timed follow-up from the study personnel are
required. The methods employed by our study could successfully be applied to analytic studies of a wide range of
clinical conditions that have been postulated to be influenced by the gut microbial population.
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After menopause, breast cancer occurs at greater frequency
in women who have high levels of estrogens [1,2]. Postmen-
opausal estradiol level is linearly related to body mass index
(BMI), reduced with surgical menopause (bilateral ovariec-
tomy), and elevated among current cigarette smokers and
heavy consumers of alcohol [3]. Differences in estrogen
levels throughout the body may also reflect differences in
estrogen metabolism and elimination, especially in feces.* Correspondence: heather.s.feigelson@kp.org
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reproduction in any medium, provided the orMetabolism of estrogens occurs predominantly in the
liver, including hydroxylation and conjugation (glucuroni-
dation, sulfation or O-methylation) [4]. Conjugated estro-
gens may be excreted in the urine or bile. From the bile,
conjugated estrogens enter the gastrointestinal tract and
interact with gut bacteria, where highly variable concen-
trations of microbial β-glucuronidase and other enzymes
de-conjugate them, following which these biologically
active hormones are reabsorbed through the mucosa
and enter the circulation through the portal vein. It is
estimated that 80% of excreted estrogens in bile are
reabsorbed [5,6]. We hypothesize that systemic estrogen
levels, and thus risk for postmenopausal breast cancer andral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Feigelson et al. BMC Research Notes 2014, 7:204 Page 2 of 6
http://www.biomedcentral.com/1756-0500/7/204perhaps other conditions, may reflect differences in the
composition or functions of the gut microbial population,
which can be measured from a single fecal sample.
An initial assessment of the bacterial population of the
distal gut can be obtained by DNA that is extracted from
feces [7]. However, collection of fecal samples for epide-
miologic research is challenging. In addition to logistical
complications, there is the potential for participation bias
related to socio-demographics, perceived risk, or other
motivations. Here we describe a study to determine the
feasibility of successfully identifying and enrolling a
representative sample of healthy postmenopausal women
and collecting from them breast cancer risk factor data,
urine and stool specimens using a mailed collection kit.
Estrogen and estrogen metabolites could be measured
from the urine samples, and fecal microbiota could be
characterized from the stool sample. The primary aims of
the Breast and Colon Health (BRanCH) feasibility study
were to pilot test study materials and specimen collection
among postmenopausal women from the general popula-
tion of Kaiser Permanente Colorado (KPCO) members,
to estimate response rates, and to identify differences
between participants and non-participants that may need
to be considered in subsequent studies.
Methods
The study protocol was developed by collaborators at
the National Cancer Institute (NCI), Kaiser Permanente
Colorado (KPCO), the Institute for Genome Sciences at
the University of Maryland School of Medicine (IGS),
and RTI International (RTI). The study protocol and all
study materials were approved by the Institutional Review
Boards at each institution.
We defined eligibility criteria as current female KPCO
members, aged 55–69, who had received a normal screen-
ing mammogram within the past 6–8 weeks. The virtual
data warehouse (VDW) at KPCO was used to identify
eligible women. The VDW is a standardized database of
inpatient and outpatient diagnoses, procedures, laboratory
results, and medications derived from the electronic
medical record (EMR) [8]. Using the VDW, we excluded
women with prescription use or conditions that could
strongly impact either the normal gut microbial popula-
tion or circulating hormone levels including the following:
any history of prior cancer (other than non-melanoma
skin cancer), inflammatory bowel disease or diverticulitis,
gastric banding or by-pass surgery; history of other gastric
or intestinal surgery (such as appendicitis) within the pre-
vious 6 months, any progesterone or estrogen hormone
prescription within the previous 12 months, and antibiotic
prescription within the previous 6 months.
Each month, approximately 2,400 women meeting the
criteria above receive notification by mail that they have
had a normal screening mammogram. From this popula-tion, we randomly sampled women to receive a recruit-
ment package containing a brochure, introductory letter,
consent document, and opt-out postcard. Two weeks
later, unless the opt-out postcard had been mailed back,
a KPCO research assistant, using a telephone script,
called the potential participant to screen for conditions
that were cause for exclusion (for example, recent anti-
biotic or hormone use or exclusionary conditions that
were not recorded in the medical record) and to review
the BRanCH study procedures and consent document.
This was a rolling recruitment linked to date of screening
mammogram, so that letters were mailed within six weeks
of mammography. Recruitment packages were sent in four
batches, approximately 1 month apart.
The first two batches included 100 women each, the
second two batches included 50 women each, for a total
of 300 potentially eligible randomly sampled women.
Participants who provided verbal consent were sent a
second package, including a self-administered cancer risk-
factor questionnaire, instructions for completing the
on-line Block Brief Food Frequency Questionnaire (FFQ)
[9], a specimen collection kit, illustrated instructions for
collecting a single urine sample and four aliquots from a
single fecal sample, and materials to ship the specimens
overnight to the biorepository.
Questionnaires, demographic, and clinical data
The self-administered risk factor survey included 77 ques-
tions on demographics, smoking, alcohol consumption,
physical activity, body habitus, dietary restrictions, con-
sumption of yogurt or probiotics, recent consumption
of high-nitrite foods, family history of cancer, bowel habits
as well as reproductive and menstrual history. A pre-
addressed, postage paid envelope was provided for return
of the completed form to RTI for double key data entry.
The on-line FFQ asks about usual dietary intake from
70 food items. It was designed to provide estimates of
usual and customary dietary intake. The food list for this
questionnaire was developed from the NHANES III diet-
ary recall data. The nutrient database was developed from
the USDA Nutrient Database for Standard Reference. In-
dividual portion size is asked, and pictures are provided
(http://www.nutritionquest.com/). When finished, the par-
ticipant could print out a free nutrition report based on
her answers. The on-line questionnaire was considered
optional because we did not know how many women
had internet access and were comfortable completing
data on-line.
Using the VDW, KPCO extracted information from the
EMR, including age, ethnicity, geocode (as a surrogate
for socioeconomic status), length of KPCO enrollment,
potentially relevant medications and diseases, BMI, radi-
ology codes for most recent mammogram, and history of
breast biopsies.
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The participant received printed illustrated instructions,
a plain cardboard shipping box, a stool catching pouch,
a Styrofoam box with a custom foam insert that held
four 10 mL screw top Sarstedt tubes, a 120 mL screw-top
container for urine (without preservative), and two gel
packs to be frozen upon receipt of the kit. The specimen
collection tubes were pre-labeled with only a unique
code number, no personal identifiers. On the self-selected
morning, excluding Friday through Sunday, the participant
collected the urine and attached the stool catching pouch
to the toilet seat. Defecating normally, the participant used
the clean scoop attached to the tube lid to collect an
aliquot, sealed the tube by screwing on the lid, and
moved on to the next tube, collecting four aliquots in
total. Two tubes were pre-loaded with 5 mL RNAlater
(Qiagen) and two with 5 mL sterile phosphate buffered
saline (PBS). The tubes were then secured in the foam
insert for shipping and frozen gel packs were added to
the shipping box. The participant called to arrange for
package pick-up and overnight delivery to the NCI
biorepository. Following receipt of the specimens at the
repository, participants were sent a gift card with a small
monetary value to convey our appreciation for their time
and effort. Specimens were sub-aliquotted and frozen for
future analysis.
Statistical analysis
Our results are primarily descriptive. Enrollment was
defined as receipt of fecal and urine specimens, as well
as the self-administered risk factor survey. We compared
enrolled women to those who refused and to those who
could not be reached by telephone using an unpaired
t-test for continuous variables (age, years of membership
at KPCO, and BMI) and chi-square or Fisher’s exact tests
for categorical variables (race/ethnicity as Non-Hispanic
White vs. other, attended college (yes/no), and history of
breast biopsy (yes/no).
Results
Over the course of six months, we intended to contact
up to 300 women, with a goal to obtain specimens from
at least 60 women. Participant recruitment occurred at
KPCO, data and biospecimen processing was managed
by RTI, urine estrogens and fecal specimens were stored at
the NCI biorepository (Frederick, MD) for future analyses
(Figure 1). The enrollment cascade is shown in Figure 2.
Of the 300 women who were mailed an invitation packet,
58 (19%) returned the “opt-out” postcard and were not
contacted further. A KPCO research assistant made up to
3 attempts to contact the remaining women by phone, of
whom 130 (43%) could not be contacted, 23 (8%) refused,
and 12 (4%) were found to be ineligible. Of those foundto be ineligible, 2 had a history of cancer; 1 was pre-
menopausal; 3 were taking estrogen; 3 had a history of
gastrointestinal disease and 3 had recent antibiotic use.
We mailed enrollment materials to 77 (26%) women who
agreed to participate. Of these, 62 women (21% of the
randomly selected population) returned specimens. Fifty-
nine (20%) women were classified as enrolled, returning
both the risk factor survey and specimens. Forty-eight
(17%) women completed the on-line food frequency ques-
tionnaire (FFQ), in addition to providing specimens and
completing the risk factor survey. Of the 14 who did not
complete the FFQ, eleven indicated they did not have
internet access. Participants spent 1–2 hours collecting
specimens, packaging them for shipment, and completing
the risk-factor questionnaire. The FFQ took 30 minutes to
complete on average.
We mailed 100 letters for each of the first two batches
of the study. On average, the research assistant made 3
phone calls on different days and spent 25 minutes to
verify eligibility, consent and enroll participants. In an
attempt to reach potential participants more quickly and
hopefully improve participation, we mailed 50 letters in
the second two batches. Enrollment by batch was: 15%
batch 1, 21% batch 2, 20% batch 3, and 26% batch 4. In
addition to reducing batch 4 to 50 letters, we accelerated
both initial and follow-up phone calls with a second
research assistant.
The age range of enrolled women was 55–69 years
(mean age 59.9 years) and the mean length of enrollment
in KPCO was 12 years. Fifty (84.7%) of the 59 enrolled
women were non-Hispanic white, 3 (5.1%) were African-
American, 1 (1.7%) was Hispanic, and race/ethnicity was
missing for 5 (8.5%) women. The majority (70.1%) of
women who enrolled had attended college. Table 1 shows
the characteristics of enrolled women who returned speci-
mens and risk factor surveys (n = 59) compared to those
who refused, either by returning the opt-out postcard or
by phone (n = 81), and women we were unable to reach by
phone (n = 130). We observed no statistically significant
differences between the three groups of enrolled, refused,
or unable to contact. However, enrolled women tended
to be non-Hispanic White (84.7%, 67.9%, and 71.5%, re-
spectively, p = 0.07), and were non-significantly more
likely to have a history of breast biopsy (6.8%, 2.5% and
5.4%, respectively, p = 0.49) than the other two groups.
The risk-factor survey included four items on the ease
or difficulty of various components of the study. We also
allowed space for open-ended response. Of the 59 returned
questionnaires, 24 had at least one comment or suggestion.
The enrolled women had few negative comments or diffi-
culties collecting the samples; only 2 found specimen
collection more difficult than they expected. The biggest
challenges mentioned for completing the study as re-
quested was the restriction to collect stool samples only
Figure 1 BRanCH Study Overview showing roles of collaborative partners and enrollment activities. NCI: National Cancer Institute; IGS:
Institute for Genome Sciences at the University of Maryland School of Medicine; RTI: RTI International.
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scheduling pick-up with the overnight courier.
Discussion
These data demonstrate that an apparently representative
sample of women from a general population can be
successfully recruited for a gut microbiome study that
involves collection of a fecal sample. Enrolled women were
generally representative of the overall sample, althoughFigure 2 Enrollment cascade and response rate.White non-Hispanic women tended to participate at a
higher rate. While the enrollment rate calculated as a
percentage of the number of women identified as poten-
tially eligible was low (20%), it is not unexpected given the
participant burden. Our 20% response rate is comparable
to those reported by other large-scale studies that have
enrolled healthy participants [10-12], but lower than is
typically reported for case–control studies [13]. Further,
once women initially agreed to participate via phone, they
Table 1 Characteristics of the study population
Enrolled1 (n = 59) Refused2 (n = 81) Unable to contact (n = 130) p-value3
Mean age (range) 59.9 (55–69) 60.7 (55–69) 59.1 (55–68) 0.54
Non-hispanic white4 84.7% 67.9% 71.5% 0.07
Mean years in KPCO 12.0 12.4 11.4 0.72
Attended College 70.1% 67.1% 66.5% 0.41
Mean BMI 28.0 26.3 29.2 0.81
History of breast biopsy 6.8% 2.5% 5.4% 0.49
1Enrolled and returned specimens and questionnaire.
2Opt-out or refused over the phone.
3p-value compares enrolled to all others.
4Self reported race/ethnicity.
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the complexity of the task at hand. Few women listed
specific problems with the specimen collection but did
spend over one hour collecting specimens, packaging
them for shipment, and completing the surveys. This
amount of time commitment requires motivated indi-
viduals. Fortunately, our study engendered this type of
motivation by clearly illustrating the importance of the
goal and the steps required to comply and by providing
reminders and other aids to the willing participant such
as easy to use materials.
The success of this type of study requires significant
personal contact and carefully timed follow-up. The
KPCO research assistant made several attempts to contact
potential participants, left messages when possible, and
usually scheduled a convenient time to call back to discuss
the study. We had better response from the last batch of
mailed letters when women were called more promptly
after receiving the letter of invitation, and follow-up calls
were made after the collection kits were mailed to check
for questions.
The KPCO Virtual Data Warehouse (VDW) facilitated
identification of eligible women for this study. Women
were identified from electronic mammography codes
indicating a normal screening mammogram within weeks
of receiving the test. We used the medical record data to
apply our exclusion criteria prior to contacting any women
for participation. At the time of the first phone call, the
research assistant verified eligibility, including recent
initiation of antibiotics or hormone therapy, and use of
over the counter or herbal hormone therapies that would
not be captured in the electronic medical record (EMR).
Because of the extensive data available in the VDW, only
4% of the women contacted by phone were ineligible.
In-home sample collection offers both conveniences
and challenges. To ensure the samples arrived at the NCI
repository during a standard Monday through Friday
working week, we requested that samples be collected
and shipped on specified days of the week (Monday –
Thursday). Although this did not greatly impact compliance
from women who agreed to participate, it was inconvenientfor many women whose work or personal schedules did
not fit easily into this sample collection time frame. Some
women also reported difficulty arranging a pick-up at their
home. To address these issues of timing in future studies,
we plan to provide participants with a sealed container that
can be stored in the home freezer. The participant will put
the urine and fecal specimens in the sealed container,
immediately put this in her freezer, and then arrange a
convenient time for the frozen samples to be picked-up
by study staff equipped with a dry ice chest. This will allow
for specimen collection to be done at the participant’s
convenience, at any time of day, any day of the week. Also,
this will ensure sample integrity, as the samples can be
batched and shipped frozen to the repository.
Conclusions
Although collection of fecal specimens from the general
population is challenging, our results show that it is
feasible. Our enrolled population was similar to those
who refused or could not be contacted. However, our
sample had limited power to identify differences between
groups, thus generalization of our results to the larger
population requires caution. Participation requires both
motivated subjects and a significant amount of phone
contact from the study staff. The methods employed
by our study could successfully be applied to analytic
studies of a wide range of clinical conditions that have
been postulated to be influenced by the gut microbial
population [14,15].
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